Shionogi

Shionogi ranks 7th on the list of the largest Japanese pharmaceutical companies. This firm is a Japanese pharmaceutical firm best known for the development of Crestor. Katakana is often used in medical supplies and brand names. Shionogi has been in business since 1878 and was incorporated in 1919. Medicines for hyperlipidemia, antibiotics, and cancer treatments are among the products manufactured. The company is traded on the Tokyo and Osaka stock exchanges and is a component of the Nikkei 225 stock index.'

Shionogi is well-known in Japan as a producer of antimicrobials and antibiotics. Because of antibiotic resistance and the slow growth of the antibiotic market, it has partnered with US-based Schering-Plough (merged in 2009 with Merck & Co.) to become the only marketing agency for its drugs in Japan. Shionogi was an early investor in Ranbaxy Pharmaceuticals, an Indian generic manufacturer. In 2012, the company acquired a stake in ViiV Healthcare, a pharmaceutical firm focused on the development of HIV treatments.

Founded: 1878
Headquarters: Osaka, Japan
Official website: https://www.shionogi.com/global/en/